How has been the historical performance of the Guj. Inject(Ker)?

Answer:The historical performance of Guj. Inject(Ker) shows significant growth in net sales, increasing from Rs 0.02 crore in March 2022 to Rs 19.05 crore in March 2025. This growth is accompanied by a rise in total operating income, which also reached Rs 19.05 crore in March 2025, compared to just Rs 0.02 crore in March 2022. The company has managed to improve its operating profit, with an operating profit (PBDIT) of Rs 1.26 crore in March 2025, up from a loss of Rs 0.38 crore in March 2023. Profit before tax has similarly improved, reaching Rs 1.25 crore in March 2025, while profit after tax stood at Rs 1.02 crore for the same period. The earnings per share (EPS) have also increased significantly to Rs 0.7 in March 2025, compared to Rs 0.07 in March 2024.

Breakdown:
The financial metrics of Guj. Inject(Ker) reflect a remarkable turnaround over the years. From negligible sales figures in previous years, the company has achieved net sales of Rs 19.05 crore by March 2025, marking a substantial increase. Total operating income mirrors this growth, reaching Rs 19.05 crore as well. The company has transitioned from operating losses to an operating profit of Rs 1.26 crore in March 2025, indicating improved operational efficiency. Profit before tax has also seen a positive trend, climbing to Rs 1.25 crore, while profit after tax reached Rs 1.02 crore, showcasing the company's ability to generate net income. Furthermore, the earnings per share have surged to Rs 0.7, highlighting the company's enhanced profitability and shareholder value. Overall, Guj. Inject(Ker) has demonstrated significant financial improvement and growth in its recent performance.